The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...
Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests ...
Cambridge, Massachusetts-- (Newsfile Corp. - March 10, 2026) - R3 Bio announced the release of its 2026 research report outlining early-stage progress in developing integrated, stem cell-derived ...
Speaking at a recent meeting of the British Pharmacological Society in Brighton, UK, Christine Mummery described how using embryonic stem cells to create human heart cells could b ...
With the National Institutes of Health shifting funding toward human-relevant, non-animal science, Connecticut’s leadership in bioscience has a timely opportunity to champion research methods that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results